Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dual specificity phosphatase 5 pseudogene 1 (DUSP5P1) is a human pseudogene and long non-coding RNA, previously annotated as FLJ34941 and DUSP5P, without protein-coding function. While DUSP5P1 lacks enzymatic/catalytic activity, its transcript is overexpressed in certain cancers—such as Hodgkin lymphoma, acute myeloid leukemia, and gastric cancer. DUSP5P1 modulates tumor cell biology by transcriptionally regulating genes involved in cell migration, invasion, and apoptosis, principally by direct regulation of genes like ARHGAP5 and influencing MAPK signaling pathways. High DUSP5P1 expression is associated with increased metastasis, drug resistance, and poor prognosis in gastric cancer patients. It is not considered a classic therapeutic target such as a receptor, enzyme, or transporter, and is instead studied as a cancer biomarker and a potential regulatory RNA involved in tumorigenesis.
Not directly applicable as a target Indirect: Modulates transcription of genes such as ARHGAP5, impacting focal adhesion and MAPK signaling; influences cell migration, invasion, and drug resistance
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dual specificity phosphatase 5 pseudogene 1 (DUSP5P1).